Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A4GNT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ABCA5 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | ABCC10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ABCC3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ABCC6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ABCG2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |